Resolving VUS to pathogenic or benign will both enable a non-invasive means of diagnosing PJS via a blood test and also support a genotype-driven approach to therapy for cancers involving somatic STK11 variation. Here, STK11 is linked to Peutz-Jeghers syndrome.